HGF and COVID-19: For this reason, through this cytokine profile in ABO blood groups, we could find HGF as a bad prognosis biomarker in all COVID-19 patients (both ABO groups), growing up to 17 times more intubation or death risk in non-O patients with persistently higher levels.